A systematic review and meta-analysis of recombinant human soluble thrombomodulin for the treatment of DIC associated with hematological malignancies

CONCLUSION: Use of rhTM in patients with hematological malignancy-associated DIC is strongly expected to be effective and safe.PMID:38270783 | DOI:10.1007/s12185-023-03704-w

Source: International Journal of Hematology - January 25, 2024 Category: Hematology Authors: Noriaki Kawano Masahiko Fukatsu Kazuma Yamakawa Yoshinobu Seki Hideo Wada Kohji Okamoto Takayuki Ikezoe Source Type: research